SciSight Ecosystem
WoS SCIE Q3Scopus Q2SCImago #8,689CAS 4区Gold OA

Transfusion Medicine and Hemotherapy

Abbreviation (ISO):TRANSFUS MED HEMOTH
Country: Switzerland•WoS SCIE Quartile: Q3•Scopus SJR: 0.671•SCImago Rank: #8,689•Identifier (ISSN):1660-3796(Print)/1424-5493(Online)•Articles / Year: 51•Estimated Publication Fee (APC): $3,127 USD
Clarivate IF (2026)Q3
2.1
↑ +0.2

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
33

33 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate5.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
51articles/year
100% Gold OA•63.04% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.1)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.1)
🔵 Computed
20251.50đ
WoS Q3(IF: 1.9)
🔵 Computed
20241.50đ
WoS Q3(IF: 1.9)
🔵 Computed
20231.50đ
WoS Q3(IF: 2.2)
🔵 Computed
20221.50đ
WoS Q3(IF: 4.04)
🔵 Computed
20211.50đ
WoS Q3(IF: 3.747)
🔵 Computed
20201.50đ
WoS Q3(IF: 1.937)
🔵 Computed
20191.50đ
WoS Q3(IF: 3)
🔵 Computed
20181.50đ
WoS Q3(IF: 2.152)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

This journal is devoted to all areas of transfusion medicine. These include the quality and security of blood products, therapy with blood components and plasma derivatives, transfusion-related questions in transplantation, stem cell manipulation, therapeutic and diagnostic problems of homeostasis, immuno-hematological investigations, and legal aspects of the production of blood products as well as hemotherapy. Both comprehensive reviews and primary publications that detail the newest work in transfusion medicine and hemotherapy promote the international exchange of knowledge within these disciplines. Consistent with this goal, continuing clinical education is also specifically addressed.

Topics Covered (Recognized by AI)
Medicine98.3%Biology37.9%Intensive care medicine33.1%Internal medicine28.3%Immunology27.7%Chemistry22.4%Genetics22.3%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,689Scopus Q2SCImago Profile
Scopus Coverage:1973, 1975-1997, 2003-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.671

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
63

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.92

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,127 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations367
3-Year Documents179
Citable Documents157

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate46.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ2
Immunology and AllergyQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
S. Karger AG
Publication Language
English
Frequency
Bimonthly
Founding Year
2003
Editorial Address
KARGER, ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
HEMATOLOGY
JCRSCIE
61/103Q3
IMMUNOLOGY
JCRSCIE
142/183Q4
HEMATOLOGY
JCISCIE
72/103Q3
IMMUNOLOGY
JCISCIE
148/183Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—348
20251.95155
20241.959198
20232.283432
20224.0472502
20213.74767524
20201.93760741
20193972,348
20182.152771,154
2017—791,100
2016—752,276
2015—811,704
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Transfusion Medicine and Hemotherapy

WoS Q3
1245201820192020202120222023202420251.90
Annual Impact Factor Metric
2025:1.9

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4fa6f802-83f3-49f3-965d-f39a4f311d06
Database Updated: 2026-10-01